William Blair Boosts Earnings Estimates for Simulations Plus

Simulations Plus, Inc. (NASDAQ:SLP - Free Report) - Analysts at William Blair upped their Q1 2025 EPS estimates for Simulations Plus in a research note issued on Tuesday, November 5th. William Blair analyst M. Smock now anticipates that the technology company will post earnings per share of $0.16 for the quarter, up from their prior forecast of $0.08. William Blair has a "Outperform" rating on the stock. The consensus estimate for Simulations Plus' current full-year earnings is $1.11 per share. William Blair also issued estimates for Simulations Plus' Q2 2025 earnings at $0.27 EPS, Q3 2025 earnings at $0.32 EPS, Q4 2025 earnings at $0.37 EPS, FY2025 earnings at $1.12 EPS, Q2 2026 earnings at $0.35 EPS, Q3 2026 earnings at $0.40 EPS, Q4 2026 earnings at $0.45 EPS and FY2026 earnings at $1.39 EPS.

Several other analysts have also recently commented on SLP. StockNews.com cut Simulations Plus from a "hold" rating to a "sell" rating in a research report on Monday. KeyCorp began coverage on Simulations Plus in a report on Monday, July 29th. They set an "overweight" rating and a $47.00 price target on the stock. JMP Securities assumed coverage on shares of Simulations Plus in a report on Tuesday, July 16th. They issued a "market perform" rating for the company. Finally, BTIG Research lowered their target price on shares of Simulations Plus from $60.00 to $50.00 and set a "buy" rating on the stock in a research note on Thursday, October 24th. One analyst has rated the stock with a sell rating, one has given a hold rating and five have assigned a buy rating to the company's stock. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and an average price target of $54.50.

Simulations Plus Stock Performance

Shares of NASDAQ:SLP traded down $0.11 during trading hours on Friday, hitting $30.59. The stock had a trading volume of 139,880 shares, compared to its average volume of 133,991. The stock's fifty day simple moving average is $31.60 and its 200 day simple moving average is $39.44. The firm has a market capitalization of $613.85 million, a price-to-earnings ratio of 62.43 and a beta of 0.71. Simulations Plus has a 1-year low of $27.22 and a 1-year high of $51.22.

Simulations Plus (NASDAQ:SLP - Get Free Report) last released its quarterly earnings results on Wednesday, October 23rd. The technology company reported $0.06 EPS for the quarter, topping the consensus estimate of $0.04 by $0.02. The business had revenue of $18.70 million during the quarter, compared to analyst estimates of $19.73 million. Simulations Plus had a net margin of 14.15% and a return on equity of 6.16%. The company's quarterly revenue was up 19.9% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.18 earnings per share.

Insider Activity at Simulations Plus

In other Simulations Plus news, Director Walter S. Woltosz sold 20,000 shares of the business's stock in a transaction dated Friday, November 1st. The shares were sold at an average price of $27.66, for a total value of $553,200.00. Following the sale, the director now directly owns 3,462,584 shares in the company, valued at approximately $95,775,073.44. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders sold 60,750 shares of company stock valued at $1,905,655 over the last 90 days. 20.90% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Simulations Plus

Institutional investors and hedge funds have recently modified their holdings of the stock. Tributary Capital Management LLC grew its position in Simulations Plus by 54.7% during the 3rd quarter. Tributary Capital Management LLC now owns 325,567 shares of the technology company's stock worth $10,425,000 after purchasing an additional 115,122 shares in the last quarter. Silvercrest Asset Management Group LLC purchased a new stake in shares of Simulations Plus during the 1st quarter worth about $4,717,000. Royce & Associates LP grew its stake in shares of Simulations Plus by 28.8% in the 3rd quarter. Royce & Associates LP now owns 237,416 shares of the technology company's stock valued at $7,602,000 after buying an additional 53,092 shares in the last quarter. Dimensional Fund Advisors LP raised its position in Simulations Plus by 10.1% during the second quarter. Dimensional Fund Advisors LP now owns 414,005 shares of the technology company's stock valued at $20,128,000 after acquiring an additional 37,992 shares in the last quarter. Finally, Congress Asset Management Co. lifted its stake in Simulations Plus by 22.5% in the third quarter. Congress Asset Management Co. now owns 206,542 shares of the technology company's stock valued at $6,613,000 after acquiring an additional 37,914 shares during the last quarter. 78.08% of the stock is owned by institutional investors and hedge funds.

Simulations Plus Company Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.